Key facts
- Notable investors include Shenzhen Yifeng Investment Management Enterprise, Beijing FOF Capital, SUNNOVO.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Yuanma Intelligent Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuanma Intelligent Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuanma Intelligent Medicine
Operator of a biotechnology company focused on gene and cell therapy. The company offers circular mRNA (cmRNA) technology and AI-powered research and development, cmRNA platform, targeted delivery systems, and AI-driven RNA design, helping clients to transform the treatment landscape for patients with unmet medical needs.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2023
- Website
- byterna.com/
- Ownership
- Privately Held (backing)
Yuanma Intelligent Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuanma Intelligent Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuanma Intelligent Medicine in its N-PORT filings yet. We sweep new filings monthly.